135 related articles for article (PubMed ID: 9492192)
21. Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies.
Bröker BM; Klajman A; Youinou P; Jouquan J; Worman CP; Murphy J; Mackenzie L; Quartey-Papafio R; Blaschek M; Collins P
J Autoimmun; 1988 Oct; 1(5):469-81. PubMed ID: 2473761
[TBL] [Abstract][Full Text] [Related]
22. Leukaemic B-cell maturation: studies on immunoglobulin secretion mediated by two signalling systems in vitro.
Antosz H; Koczkodaj D; Kwiatkowska-Drabik B; Wach W
Cytobios; 1995; 84(336):31-40. PubMed ID: 8681608
[TBL] [Abstract][Full Text] [Related]
23. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.
Armitage RJ; Macduff BM; Spriggs MK; Fanslow WC
J Immunol; 1993 May; 150(9):3671-80. PubMed ID: 8097223
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
Suzuki T; Cooper MD
J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
[TBL] [Abstract][Full Text] [Related]
25. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
Schena M; Larsson LG; Gottardi D; Gaidano G; Carlsson M; Nilsson K; Caligaris-Cappio F
Blood; 1992 Jun; 79(11):2981-9. PubMed ID: 1375120
[TBL] [Abstract][Full Text] [Related]
26. Effects of a phorbol ester on activation and immortalization of leukaemic B cells by Epstein-Barr virus.
Walls EV; Crawford DH
Leuk Res; 1990; 14(4):389-91. PubMed ID: 2159092
[TBL] [Abstract][Full Text] [Related]
27. Expression and production of cytokines by heterohybrids and their parental B cells in CLL.
Diaw L; Lefebvre d'Hellencourt C; Cornillet I; Vuillier F; Guenounou M; Dighiero G
Leuk Lymphoma; 1996 Apr; 21(3-4):281-91. PubMed ID: 8726409
[TBL] [Abstract][Full Text] [Related]
28. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5- B lymphocytes.
Nawata Y; Stall AM; Herzenberg LA; Eugui EM; Allison AC
Int Immunol; 1990; 2(7):603-14. PubMed ID: 1703783
[TBL] [Abstract][Full Text] [Related]
29. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
30. CD5-like phorbol-ester responsiveness in conventional B cells activated through surface immunoglobulin.
Rothstein TL; Kolber DL; Cohen DP
Ann N Y Acad Sci; 1992 May; 651():176-8. PubMed ID: 1376037
[No Abstract] [Full Text] [Related]
31. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
32. Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay.
Tucci A; James H; Chicheportiche R; Bonnefoy JY; Dayer JM; Zubler RH
J Immunol; 1992 May; 148(9):2778-84. PubMed ID: 1315359
[TBL] [Abstract][Full Text] [Related]
33. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
Walker C; Bettens F; Pichler WJ
Eur J Immunol; 1987 Jun; 17(6):873-80. PubMed ID: 2439351
[TBL] [Abstract][Full Text] [Related]
34. Requirements for induction of activation and proliferation of human B cells analysed with anti-idiotype monoclonal antibodies.
de Rie MA; van Lier RA; Imholz MJ; Schumacher TN; van Schijndel GM; Miedema F
Scand J Immunol; 1989 Aug; 30(2):249-57. PubMed ID: 2474851
[TBL] [Abstract][Full Text] [Related]
35. Impaired mitogen responses of the non-leukaemic B cells from patients with chronic lymphocytic leukaemia.
Morgan A; Eaves J; Mockford JW; Malkovska V
Clin Exp Immunol; 1989 Aug; 77(2):239-44. PubMed ID: 2789117
[TBL] [Abstract][Full Text] [Related]
36. Anti CD5 sustains the proliferative response of IgM-activated human CD5+ B cells.
Jamin C; Dueymes M; Lydyard PM; Youinou P
Scand J Immunol; 1995 Aug; 42(2):282-5. PubMed ID: 7543217
[TBL] [Abstract][Full Text] [Related]
37. Functional properties of human germinal center B cells.
Butch AW; Nahm MH
Cell Immunol; 1992 Apr; 140(2):331-44. PubMed ID: 1544165
[TBL] [Abstract][Full Text] [Related]
38. B-cell maturation in chronic lymphocytic leukaemia. IV. T-cell-dependent activation of leukaemic B cells by staphylococcal enterotoxin 'superantigens'.
Duan X; Nerl C; Janssen O; Kabelitz D
Immunology; 1992 Mar; 75(3):420-6. PubMed ID: 1572690
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
[TBL] [Abstract][Full Text] [Related]
40. Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells.
Vilpo J; Hulkkonen J; Hurme M; Vilpo L
Leukemia; 2002 Sep; 16(9):1691-8. PubMed ID: 12200683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
